194 related articles for article (PubMed ID: 34950604)
1. Characteristics of Fecal Microbiota and Machine Learning Strategy for Fecal Invasive Biomarkers in Pediatric Inflammatory Bowel Disease.
Wang X; Xiao Y; Xu X; Guo L; Yu Y; Li N; Xu C
Front Cell Infect Microbiol; 2021; 11():711884. PubMed ID: 34950604
[TBL] [Abstract][Full Text] [Related]
2. A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease.
Gacesa R; Vich Vila A; Collij V; Mujagic Z; Kurilshikov A; Voskuil MD; Festen EAM; Wijmenga C; Jonkers DMAE; Dijkstra G; Fu J; Zhernakova A; Imhann F; Weersma RK
Gut Microbes; 2021; 13(1):1943288. PubMed ID: 34313538
[TBL] [Abstract][Full Text] [Related]
3. 16S sequencing and functional analysis of the fecal microbiome during treatment of newly diagnosed pediatric inflammatory bowel disease.
Ashton JJ; Colquhoun CM; Cleary DW; Coelho T; Haggarty R; Mulder I; Batra A; Afzal NA; Beattie RM; Scott KP; Ennis S
Medicine (Baltimore); 2017 Jun; 96(26):e7347. PubMed ID: 28658154
[TBL] [Abstract][Full Text] [Related]
4. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
[TBL] [Abstract][Full Text] [Related]
5. Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
Bosch S; van Gaal N; Zuurbier RP; Covington JA; Wicaksono AN; Biezeveld MH; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ
Inflamm Bowel Dis; 2018 Oct; 24(11):2468-2475. PubMed ID: 29788410
[TBL] [Abstract][Full Text] [Related]
6. Using gut microbiota as a diagnostic tool for colorectal cancer: machine learning techniques reveal promising results.
Lu F; Lei T; Zhou J; Liang H; Cui P; Zuo T; Ye L; Chen H; Huang J
J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37288545
[No Abstract] [Full Text] [Related]
7. Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients.
Doherty MK; Ding T; Koumpouras C; Telesco SE; Monast C; Das A; Brodmerkel C; Schloss PD
mBio; 2018 Mar; 9(2):. PubMed ID: 29535202
[TBL] [Abstract][Full Text] [Related]
8. Identification of FCN1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases.
Chen X; Gao Y; Xie J; Hua H; Pan C; Huang J; Jing M; Chen X; Xu C; Gao Y; Li P
J Transl Med; 2023 Mar; 21(1):203. PubMed ID: 36932401
[TBL] [Abstract][Full Text] [Related]
9. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents.
Levine A; Koletzko S; Turner D; Escher JC; Cucchiara S; de Ridder L; Kolho KL; Veres G; Russell RK; Paerregaard A; Buderus S; Greer ML; Dias JA; Veereman-Wauters G; Lionetti P; Sladek M; Martin de Carpi J; Staiano A; Ruemmele FM; Wilson DC;
J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):795-806. PubMed ID: 24231644
[TBL] [Abstract][Full Text] [Related]
10. Leveraging 16S rRNA Microbiome Sequencing Data to Identify Bacterial Signatures for Irritable Bowel Syndrome.
Liu Y; Li W; Yang H; Zhang X; Wang W; Jia S; Xiang B; Wang Y; Miao L; Zhang H; Wang L; Wang Y; Song J; Sun Y; Chai L; Tian X
Front Cell Infect Microbiol; 2021; 11():645951. PubMed ID: 34178718
[TBL] [Abstract][Full Text] [Related]
11. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S
Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624
[No Abstract] [Full Text] [Related]
12. Gut microbiome-based supervised machine learning for clinical diagnosis of inflammatory bowel diseases.
Manandhar I; Alimadadi A; Aryal S; Munroe PB; Joe B; Cheng X
Am J Physiol Gastrointest Liver Physiol; 2021 Mar; 320(3):G328-G337. PubMed ID: 33439104
[TBL] [Abstract][Full Text] [Related]
13. Heptadecanoic acid and pentadecanoic acid crosstalk with fecal-derived gut microbiota are potential non-invasive biomarkers for chronic atrophic gastritis.
Gai X; Qian P; Guo B; Zheng Y; Fu Z; Yang D; Zhu C; Cao Y; Niu J; Ling J; Zhao J; Shi H; Liu G
Front Cell Infect Microbiol; 2022; 12():1064737. PubMed ID: 36699724
[TBL] [Abstract][Full Text] [Related]
14. Sex-based differences in fecal short-chain fatty acid and gut microbiota in irritable bowel syndrome patients.
Sun QH; Liu ZJ; Zhang L; Wei H; Song LJ; Zhu SW; He MB; Duan LP
J Dig Dis; 2021 May; 22(5):246-255. PubMed ID: 33822477
[TBL] [Abstract][Full Text] [Related]
15. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
16. Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.
Chehoud C; Albenberg LG; Judge C; Hoffmann C; Grunberg S; Bittinger K; Baldassano RN; Lewis JD; Bushman FD; Wu GD
Inflamm Bowel Dis; 2015 Aug; 21(8):1948-56. PubMed ID: 26083617
[TBL] [Abstract][Full Text] [Related]
17. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
[TBL] [Abstract][Full Text] [Related]
18. Potential of Gut Microbe-Derived Extracellular Vesicles to Differentiate Inflammatory Bowel Disease Patients from Healthy Controls.
Heo M; Park YS; Yoon H; Kim NE; Kim K; Shin CM; Kim N; Lee DH
Gut Liver; 2023 Jan; 17(1):108-118. PubMed ID: 36424722
[TBL] [Abstract][Full Text] [Related]
19. Altered Fecal Microbiota Composition in Older Adults With Frailty.
Xu Y; Wang Y; Li H; Dai Y; Chen D; Wang M; Jiang X; Huang Z; Yu H; Huang J; Xiong Z
Front Cell Infect Microbiol; 2021; 11():696186. PubMed ID: 34485176
[TBL] [Abstract][Full Text] [Related]
20. Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease.
Wedenoja S; Saarikivi A; Mälkönen J; Leskinen S; Lehto M; Adeshara K; Tuokkola J; Nikkonen A; Merras-Salmio L; Höyhtyä M; Hörkkö S; Haaramo A; Salonen A; de Vos WM; Korpela K; Kolho KL
PLoS One; 2022; 17(6):e0269561. PubMed ID: 35679312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
